Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Peri-operative and Post-operative Management of Patients with Crohn's Disease and Ulcerative Colitis.

Barnes EL, Lightner AL, Regueiro M.

Clin Gastroenterol Hepatol. 2019 Oct 4. pii: S1542-3565(19)31091-2. doi: 10.1016/j.cgh.2019.09.040. [Epub ahead of print] Review.

PMID:
31589972
2.

Predictors of Inadequate Response to Budesonide Multimatrix in Real-World Patients with Ulcerative Colitis.

Greenberg S, Herfarth HH, Barnes EL.

Inflamm Intest Dis. 2019 Aug;4(3):115-122. doi: 10.1159/000501004. Epub 2019 Jul 10.

PMID:
31559263
3.

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-World Evidence in U.S. Adults.

Wang T, Yang JY, Buse JB, Pate V, Tang H, Barnes EL, Sandler RS, Stürmer T.

Diabetes Care. 2019 Aug 30. pii: dc190162. doi: 10.2337/dc19-0162. [Epub ahead of print]

PMID:
31471377
4.

Opportunistic Infections and Opportunities for Action.

Barnes EL.

Inflamm Bowel Dis. 2019 Jul 17. pii: izz151. doi: 10.1093/ibd/izz151. [Epub ahead of print] No abstract available.

PMID:
31314889
5.

Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment.

Herfarth H, Barnes EL, Long MD, Isaacs KL, Leith T, Silverstein M, Gerardin Y, Kassam Z.

Inflamm Intest Dis. 2019 May;4(1):1-6. doi: 10.1159/000497042. Epub 2019 Mar 29.

PMID:
31172007
6.

Bariatric Surgery Is a Safe and Effective Option for Patients with Inflammatory Bowel Diseases: A Case Series and Systematic Review of the Literature.

Hudson JL, Barnes EL, Herfarth HH, Isaacs KL, Jain A.

Inflamm Intest Dis. 2019 Apr;3(4):173-179. doi: 10.1159/000496925. Epub 2019 Mar 19.

7.

A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.

Barnes EL, Kappelman MD, Long MD, Evon DM, Martin CF, Sandler RS.

Am J Gastroenterol. 2019 Apr;114(4):640-647. doi: 10.14309/ajg.0000000000000177.

PMID:
30848727
8.

Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.

Gregory M, Weaver KN, Hoversten P, Hicks SB, Patel D, Ciorba MA, Gutierrez AM, Beniwal-Patel P, Palam S, Syal G, Herfarth HH, Christophi G, Raffals L, Barnes EL, Deepak P.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1569-1576. doi: 10.1093/ibd/izz030.

PMID:
30810748
9.

The Incidence and Definition of Crohn's Disease of the Pouch: A Systematic Review and Meta-analysis.

Barnes EL, Kochar B, Jessup HR, Herfarth HH.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1474-1480. doi: 10.1093/ibd/izz005.

PMID:
30698715
10.

Scope of Burnout Among Young Gastroenterologists and Practical Solutions from Gastroenterology and Other Disciplines.

Barnes EL, Ketwaroo GA, Shields HM.

Dig Dis Sci. 2019 Feb;64(2):302-306. doi: 10.1007/s10620-018-5443-3. Review.

PMID:
30607687
11.

High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.

Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1248-1254. doi: 10.1093/ibd/izy378.

PMID:
30590700
12.

Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, Jensen ET, Shaheen NJ, Barritt AS, Lieber SR, Kochar B, Barnes EL, Fan YC, Pate V, Galanko J, Baron TH, Sandler RS.

Gastroenterology. 2019 Jan;156(1):254-272.e11. doi: 10.1053/j.gastro.2018.08.063. Epub 2018 Oct 10. Review. Erratum in: Gastroenterology. 2019 May;156(6):1936.

PMID:
30315778
13.

Thrombotic and Infectious Risks of Parenteral Nutrition in Hospitalized Pediatric Inflammatory Bowel Disease.

Egberg MD, Galanko JA, Barnes EL, Kappelman MD.

Inflamm Bowel Dis. 2019 Feb 21;25(3):601-609. doi: 10.1093/ibd/izy298.

PMID:
30304444
14.

Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.

Weaver KN, Gregory M, Syal G, Hoversten P, Hicks SB, Patel D, Christophi G, Beniwal-Patel P, Isaacs KL, Raffals L, Deepak P, Herfarth HH, Barnes EL.

Inflamm Bowel Dis. 2019 Mar 14;25(4):767-774. doi: 10.1093/ibd/izy302.

PMID:
30295784
15.

Response to Levenstein and Prantera.

Kochar B, Barnes EL, Long MD, Cushing KC, Galanko J, Martin CF, Raffals LE, Sandler RS.

Am J Gastroenterol. 2018 Oct;113(10):1559. doi: 10.1038/s41395-018-0223-4. Epub 2018 Aug 31. No abstract available.

PMID:
30171218
16.

Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.

Herfarth H, Barnes EL, Valentine JF, Hanson J, Higgins PDR, Isaacs KL, Jackson S, Osterman MT, Anton K, Ivanova A, Long MD, Martin C, Sandler RS, Abraham B, Cross RK, Dryden G, Fischer M, Harlan W, Levy C, McCabe R, Polyak S, Saha S, Williams E, Yajnik V, Serrano J, Sands BE, Lewis JD; Clinical Research Alliance of the Crohn’s and Colitis Foundation.

Gastroenterology. 2018 Oct;155(4):1098-1108.e9. doi: 10.1053/j.gastro.2018.06.046. Epub 2018 Jun 30.

17.

Asians have more perianal Crohn disease and ocular manifestations compared with white Americans.

Kochar B, Barnes EL, Herfarth HH, Martin CF, Ananthakrishnan AN, McGovern D, Long M, Sandler RS.

Inflamm Intest Dis. 2018 Mar;2(3):147-153. doi: 10.1159/000484347. Epub 2017 Nov 18.

18.

Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease.

Barnes EL, Kochar B, Long MD, Pekow J, Ananthakrishnan A, Anyane-Yeboa A, Martin C, Galanko J, Herfarth HH, Kappelman MD, Sandler RS.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2634-2640. doi: 10.1093/ibd/izy179.

PMID:
29788063
19.

Delayed Ileal Pouch Anal Anastomosis Has a Lower 30-Day Adverse Event Rate: Analysis From the National Surgical Quality Improvement Program.

Kochar B, Barnes EL, Peery AF, Cools KS, Galanko J, Koruda M, Herfarth HH.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1833-1839. doi: 10.1093/ibd/izy082.

20.

Response to Dai et al. and Gracie et al.

Kochar B, Barnes EL, Long MD, Cushing KC, Galanko J, Martin CF, Raffals LE, Sandler RS.

Am J Gastroenterol. 2018 May;113(5):774-775. doi: 10.1038/s41395-018-0037-4. Epub 2018 Apr 23. No abstract available.

PMID:
29681625
21.

Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.

Barnes EL, Kappelman MD.

Am J Gastroenterol. 2018 Feb;113(2):273-275. doi: 10.1038/ajg.2017.431.

PMID:
29467539
22.

Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.

Marchioni Beery RM, Barnes EL, Nadkarni A, Korzenik JR.

Inflamm Bowel Dis. 2017 Dec 19;24(1):25-34. doi: 10.1093/ibd/izx005.

PMID:
29272476
23.

Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.

Barnes EL, Kochar B, Long MD, Martin CF, Kappelman MD.

Inflamm Bowel Dis. 2017 Dec;23(12):2189-2196. doi: 10.1097/MIB.0000000000001267.

24.

Depression Is Associated With More Aggressive Inflammatory Bowel Disease.

Kochar B, Barnes EL, Long MD, Cushing KC, Galanko J, Martin CF, Raffals LE, Sandler RS.

Am J Gastroenterol. 2018 Jan;113(1):80-85. doi: 10.1038/ajg.2017.423. Epub 2017 Nov 14.

25.

The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease.

Barnes EL, Kochar B, Long MD, Martin CF, Crockett SD, Korzenik JR, Kappelman MD.

J Pediatr. 2017 Dec;191:184-189.e1. doi: 10.1016/j.jpeds.2017.08.042. Epub 2017 Oct 14.

26.

The Usefulness of Serologic Testing for Epstein-Barr Virus Before Initiation of Therapy for Inflammatory Bowel Disease.

Barnes EL, Herfarth HH.

Gastroenterology. 2017 Oct;153(4):1167. doi: 10.1053/j.gastro.2017.04.055. Epub 2017 Sep 4. No abstract available.

PMID:
28881185
27.

The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.

Qazi T, Amaratunga T, Barnes EL, Fischer M, Kassam Z, Allegretti JR.

Gut Microbes. 2017 Nov 2;8(6):574-588. doi: 10.1080/19490976.2017.1353848. Epub 2017 Sep 12. Review.

28.

An active learning curriculum improves fellows' knowledge and faculty teaching skills.

Inra JA, Pelletier S, Kumar NL, Barnes EL, Shields HM.

Adv Med Educ Pract. 2017 May 26;8:359-364. doi: 10.2147/AMEP.S135538. eCollection 2017.

29.

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.

Ananthakrishnan AN, Sakuraba A, Barnes EL, Pekow J, Raffals L, Long MD, Sandler RS.

Aliment Pharmacol Ther. 2017 Jul;46(2):162-168. doi: 10.1111/apt.14125. Epub 2017 May 3.

30.

Do Shared Exposures Link the Lungs and Gut? Association Between Asthma and Inflammatory Bowel Disease.

Barnes EL, Kappelman MD.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1353-1354. doi: 10.1016/j.cgh.2017.04.030. Epub 2017 Apr 27. No abstract available.

PMID:
28458009
31.

Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis.

Barnes EL, Herfarth HH, Sandler RS, Chen W, Jaeger E, Nguyen VM, Robb AR, Kappelman MD, Martin CF, Long MD.

Inflamm Bowel Dis. 2017 Jul;23(7):1218-1224. doi: 10.1097/MIB.0000000000001119.

32.

Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.

Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, Crockett SD.

Inflamm Bowel Dis. 2017 Jun;23(6):875-881. doi: 10.1097/MIB.0000000000001121.

33.

Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab.

Allegretti JR, Barnes EL, Stevens B, Storm M, Ananthakrishnan A, Yajnik V, Korzenik J.

Dig Dis Sci. 2017 Jun;62(6):1590-1596. doi: 10.1007/s10620-017-4549-3. Epub 2017 Mar 29.

34.

High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates.

Barnes EL, Nestor M, Onyewadume L, de Silva PS, Korzenik JR; DREAM Investigators.

Clin Gastroenterol Hepatol. 2017 Sep;15(9):1390-1396.e1. doi: 10.1016/j.cgh.2016.12.036. Epub 2017 Jan 18.

35.

New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.

Barnes EL, Burakoff R.

Inflamm Bowel Dis. 2016 Dec;22(12):2956-2965. Review.

36.

Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.

Barnes EL, Goldin A, Winter RW, Collins E, Cao B, Carrellas M, Crowell AM, Korzenik JR.

Dig Dis Sci. 2016 Nov;61(11):3261-3269. Epub 2016 Sep 17.

37.

Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.

Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik JR, Winter RW.

Inflamm Bowel Dis. 2016 Sep;22(9):2229-37. doi: 10.1097/MIB.0000000000000899.

38.

Use of blood based biomarkers in the evaluation of Crohn's disease and ulcerative colitis.

Barnes EL, Liew CC, Chao S, Burakoff R.

World J Gastrointest Endosc. 2015 Nov 25;7(17):1233-7. doi: 10.4253/wjge.v7.i17.1233.

39.

Are Anti-Tumor Necrosis Factor Trough Levels Predictive of Mucosal Healing in Patients With Inflammatory Bowel Disease?: A Systematic Review and Meta-Analysis.

Barnes EL, Allegretti JR.

J Clin Gastroenterol. 2016 Oct;50(9):733-41. doi: 10.1097/MCG.0000000000000441. Review.

PMID:
26535480
40.

Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.

Allegretti JR, Barnes EL, Cameron A.

Inflamm Bowel Dis. 2015 May;21(5):1089-97. doi: 10.1097/MIB.0000000000000338.

41.

Got milk? An unusual cause of abdominal pain.

Barnes EL, Lee LS.

Gastroenterology. 2015 Mar;148(3):e1-2. doi: 10.1053/j.gastro.2014.09.035. Epub 2015 Jan 28. No abstract available.

42.

A comparative analysis of LEF-1 in odontogenic and salivary tumors.

Bilodeau EA, Acquafondata M, Barnes EL, Seethala RR.

Hum Pathol. 2015 Feb;46(2):255-9. doi: 10.1016/j.humpath.2014.10.018. Epub 2014 Nov 12.

PMID:
25497834
43.

Colorectal cancer in women: hormone replacement therapy and chemoprevention.

Barnes EL, Long MD.

Climacteric. 2012 Jun;15(3):250-5. doi: 10.3109/13697137.2012.659450. Review.

PMID:
22612611
44.
45.

Rare Malignant and Benign Salivary Gland Epithelial Tumors.

Seethala RR, Barnes EL.

Surg Pathol Clin. 2011 Dec;4(4):1217-72. doi: 10.1016/j.path.2011.07.006.

PMID:
26837791
46.

Common Malignant Salivary Gland Epithelial Tumors.

Seethala RR, Barnes EL.

Surg Pathol Clin. 2011 Dec;4(4):1177-215. doi: 10.1016/j.path.2011.07.005.

PMID:
26837790
47.

Lymphadenoma of the salivary gland: clinicopathological and immunohistochemical analysis of 33 tumors.

Seethala RR, Thompson LD, Gnepp DR, Barnes EL, Skalova A, Montone K, Kane S, Lewis JS Jr, Solomon LW, Simpson RH, Khan A, Prasad ML.

Mod Pathol. 2012 Jan;25(1):26-35. doi: 10.1038/modpathol.2011.135. Epub 2011 Sep 2.

48.

Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.

García JJ, Hunt JL, Weinreb I, McHugh JB, Barnes EL, Cieply K, Dacic S, Seethala RR.

Hum Pathol. 2011 Dec;42(12):2001-9. doi: 10.1016/j.humpath.2011.02.028. Epub 2011 Jul 20.

PMID:
21777943
49.

Narcotic use for inflammatory bowel disease and risk factors during hospitalization.

Long MD, Barnes EL, Herfarth HH, Drossman DA.

Inflamm Bowel Dis. 2012 May;18(5):869-76. doi: 10.1002/ibd.21806. Epub 2011 Jul 7.

50.

Pathology archive: evaluation of integrity, regulatory compliance, and construction of searchable database from print reports.

Smith MA, Barnes EL, Chiosea SI.

Am J Clin Pathol. 2011 May;135(5):753-9. doi: 10.1309/AJCP3CVA2NAVUUVU.

PMID:
21502430

Supplemental Content

Loading ...
Support Center